Xiamen Amoytop Biotech Co. starts sales of long-acting Paigebin PEGinterferon-2b

Nov 1, 2016

The injectable biologic is directed towards the treatment of chronic viral hepatitis.

China Bio news release, November 1, 2016

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny